Vaughan Morrill, Jr., Appellee/cross-Appellant v. Becton, Dickinson and Company, Appellant/cross-Appellee

747 F.2d 1217
CourtCourt of Appeals for the Eighth Circuit
DecidedDecember 14, 1984
Docket83-1687, 83-1731
StatusPublished
Cited by28 cases

This text of 747 F.2d 1217 (Vaughan Morrill, Jr., Appellee/cross-Appellant v. Becton, Dickinson and Company, Appellant/cross-Appellee) is published on Counsel Stack Legal Research, covering Court of Appeals for the Eighth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Vaughan Morrill, Jr., Appellee/cross-Appellant v. Becton, Dickinson and Company, Appellant/cross-Appellee, 747 F.2d 1217 (8th Cir. 1984).

Opinion

McMILLIAN, Circuit Judge.

Becton, Dickinson & Co. (B-D), a New Jersey corporation, appeals from a final judgment entered against it in the district court 1 in the amount of $3,000,000 actual damages and $20,000,000 punitive damages. Judgment was entered on jury verdicts in favor of Vaughan Morrill, Jr., an inventor and resident of Missouri, in his action for unpaid royalties due under patent license agreements and for actual and punitive damages for fraud. The jury awarded Morrill $2,125,000 actual damages on the breach of contract claim and $3,000,-000 actual damages on the fraud claim. On Morrill’s motion, the district court reduced the actual damages for fraud to $875,000 to eliminate duplication of actual damages. B-D argues that the district court’s judgment should be reversed because (1) the jury adopted an unreasonable interpretation of the agreement, (2) the elements of fraud were not established, (3) the awards of actual damages were not supported by the evidence, (4) the statute of limitations bars recovery of part of the actual damages awarded, and (5) the punitive damages award is excessive. In a cross-appeal, Morrill argues that the district court erred in denying his motion for attorney’s fees for B-D’s bad faith conduct in filing counterclaims. For the reasons discussed below, we modify the actual damages to $2,125,000 and hold that the judgment for punitive damages should be affirmed, provided Morrill accepts a remittitur reducing punitive damages to $3,000,-000. We affirm the district court’s denial of Morrill’s motion for attorney’s fees.

*1220 B-D is a company engaged in the business of manufacturing, marketing and developing a variety of health-care instruments and apparatus comprised of uniform precision-bore glass tubing. Morrill is an inventor in the field of glass technology. On May 3, 1961, the parties entered into an Exclusive License Agreement whereby Morrill granted B-D exclusive rights to Morrill’s inventions and patent rights in return for royalty payments in varying percentage amounts of the net sales of various products, payable on a quarterly basis. Morrill was to receive a 1% royalty on “Group B” products, which were products commercially developed by B-D after the effective date of the agreement. By letter agreement dated September 25, 1963, Unopette disposable pipettes, a B-D product which includes a capillary tube as a component part, was specifically added as a “Group B” product. The parties agreed to reduce the royalty on the net sales of-Unopettes to V2% on the condition that B-D pay Morrill a minimum of $5,000 per year until such time as his royalties computed on net sales of said product would exceed this minimum.

On April 13, 1970, the parties entered into a new licensing agreement giving B-D exclusive rights to Morrill’s inventions and patent rights and providing for royalty payments as follows: l%r2% of net sales of certain named listed products or “any new Product which replaces any of the Products listed,” and 5% of net sales of any other new product. The agreement provided for a five-year royalty period as to products embodying Morrill’s unpatented inventions and for a royalty period co-extensive with the effective life of Morrill’s patent rights (i.e., until September 1985) as to products embodying those patents. The second agreement also provided that it did not include those inventions covered by the 1961 agreement which was to remain in effect.

Use of Morrill’s technology enabled B-D to capture over 90% of the world market for precision-bore glass tubing principally used in the health-care industry. Over the years, B-D’s royalty statements to Morrill contained factual inaccuracies as to price, quantity of sales and classification of products resulting in underpayments to Morrill. In the late 1960’s, B-D knew that Unopette sales were generating royalties in excess of $5,000 per year, yet payments to Morrill remained at that minimum amount. In 1970 B-D unilaterally adopted a new interpretation of the 1961 agreement as amended, whereby only the capillary tube portion of Unopettes was subject to royalty payments. B-D accordingly prorated the royalties owed Morrill on Unopette sales, with the result that the $5,000 yearly minimum was not exceeded for any past year. Morrill was not informed of this decision until February 1971. In October 1971, B-D granted Morrill a limited sub-license to use his inventions and patents to manufacture a certain non-health-care industry product. At this time Morrill agreed in writing to the pro-rata method of calculating Unopette royalties.

In late 1979, B-D, faced with the prospect of having to pay Morrill sizable royalties on two new products, requested its in-house counsel to review B-D’s obligations to Morrill under the license agreements. Counsel advised that the five-year royalty clause in the 1970 agreement could be read to apply to these products because “patent rights,” strictly construed, were not in fact being used in producing them. This position, which would mean termination of royalty payments on many products, was not adopted by B-D. Rather, in early 1980, B-D adopted the position that the 1% royalty rate of the 1961 agreement, rather than the 5% rate of the 1970 agreement, covered certain products and, without informing Morrill of this decision, began assigning the lower royalty rate to the products. At the same time B-D assigned the lower rate to products it had, by oversight, failed to pay royalties on since 1976.

Morrill initiated the present lawsuit in February 1981. Count I alleged breach of contract on the part of B-D and sought the amount of royalties actually due him under the license agreements. Count II alleged that B-D’s reporting inaccuracies and mis *1221 representations of the amount of royalties due were willful and intentional in breach of B-D’s fiduciary duty, and that Morrill justifiably relied on the misrepresentations and was damaged thereby. Morrill sought actual and punitive damages under Count II. B-D asserted three counterclaims against Morrill, all of which were dismissed on B-D’s motions prior to or during trial.

At trial each side introduced evidence to support its interpretation of the license agreements and B-D’s obligations thereunder. B-D’s position was that (1) the five-year royalty clause in the 1970 agreement applied to many products because “patent rights” were not in fact being used in producing those products, (2) the 1961 agreement with its lower royalty rates, and not the 1970 agreement, covered many of BD’s products, based on the exclusionary clause in the 1970 agreement which provided that the term “inventions” as used in that agreement shall not include those inventions covered by the earlier agreement, and (3) under the 1970 agreement, certain products were “replacement” products subject to a l%-2% royalty rate, and not “new” products subject to the 5% royalty rate.

Morrill presented evidence that it was the understanding and intent of both parties that (1) the royalty period co-extensive with the life of his patent rights was the applicable royalty period under the 1970 agreement on all B-D products involved in this action, (2) following the effective date of the 1970 agreement, the royalty rates in the 1961 agreement only applied to Unopettes, and (3) under the 1970 agreement, “replacement” products referred to a very narrow class of products, including none of the products involved in this case.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Curtis Lumber Co., Inc. v. Louisiana Pacific Corp.
618 F.3d 762 (Eighth Circuit, 2010)
Exxon Mobil Corp. v. ALA. DEPT. OF CONSERVATION AND NATURAL RESOURCES
986 So. 2d 1093 (Supreme Court of Alabama, 2007)
Hunt Petroleum Corp. v. State
901 So. 2d 1 (Supreme Court of Alabama, 2004)
Reis v. Peabody Coal Co.
997 S.W.2d 49 (Missouri Court of Appeals, 1999)
Grynberg v. Citation Oil & Gas Corp.
1997 SD 121 (South Dakota Supreme Court, 1997)
Hendrickson v. Peabody Coal Co.
37 F. Supp. 2d 947 (W.D. Kentucky, 1997)
Johns Hopkins Hospital v. Peabody Coal Co.
920 F. Supp. 738 (W.D. Kentucky, 1996)
John Thornton v. First State Bank of Joplin
4 F.3d 650 (First Circuit, 1993)
Glass Design Imports, Inc. v. Rastal GmbH & Co. KG
672 F. Supp. 419 (W.D. Missouri, 1987)
Morrissey v. Welsh Co.
821 F.2d 1294 (Eighth Circuit, 1987)
MACHINE MAINTENANCE & EQUIP. v. Cooper Industries
661 F. Supp. 1112 (E.D. Missouri, 1987)
Iota Management Corp. v. Boulevard Investment Co.
731 S.W.2d 399 (Missouri Court of Appeals, 1987)
LaVay Corp. v. Dominion Federal Savings & Loan Ass'n
645 F. Supp. 612 (E.D. Virginia, 1986)
Praprotnik v. City of St. Louis
798 F.2d 1168 (Eighth Circuit, 1986)
American Business Interiors, Inc. v. Haworth, Inc.
798 F.2d 1135 (Eighth Circuit, 1986)

Cite This Page — Counsel Stack

Bluebook (online)
747 F.2d 1217, Counsel Stack Legal Research, https://law.counselstack.com/opinion/vaughan-morrill-jr-appelleecross-appellant-v-becton-dickinson-and-ca8-1984.